维普期刊资源整合服务平台（V6.5）

44篇 您的检索式：作者名="Grayson ML"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	多西环素可否替代大环内酯类药物用于治疗社区获得性肺炎显示文摘2007年美国感染病学会制定的社区获得性肺炎(CAP)诊治指南推荐经验性使用呼吸喹诺酮类或8内酰胺类联合大环内酯类药物治疗CAP非ICU住院患者。大环内酯类药物中的阿奇霉素因与其他药物相互作用少,服用方便和安全性高而被广泛使用。但是最近有研究报道阿奇霉素可能增加患者的心血管死亡风险。与未接受抗生素治疗的对照组相比,阿奇霉素治疗5d心血管病患者死亡和全因死亡危害比分别为2.88和1.85。	Teh B Grayson ML Johnson PD 周芬芬黄海辉	2014	中国感染与化疗杂志2014，14，4：	2
2	Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution 显示文摘	Grayson ML Eliopoulos GM Wennersten CB	1991	Antimicrobial Agents and Chemotherapy1991，35，11：	1
3	Significant reductions in methicillin - resistant Staphylococcus aureus bacteraemia and clinical isolates associated with a multisite, hand hygiene culture- change program and subsequent successful state- wide roll- out显示文摘	Grayson ML Jarvie LJ Martin R	2008	Med J Aust2008，188，11：	1
4	Risk factors for adverse cutaneous reactions associated with intravenous vancomycin 显示文摘	Korman TM Tumidge JD Grayson ML	2007	JAntimicrob Chemother2007，39，3：	1
5	Risk factors for adverse cutaneous reactions associated with intravenous vancomycin显示文摘	Korman TM Turnidge JD Grayson ML	1997	J Antimicrob Chemother1997，39，3：	1
6	Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus 显示文摘	Howden BP Grayson ML	2006	Clin Infect Dis2006，42，3：	1
7	Inducible re- sistance to elindamycin in Staphylococcus aureus : val- idation of Vitek-2 against CLSI D-test显示文摘	Gardiner BJ Grayson ML Wood GM	2013	Pathology2013，45，2：	1
8	Risk factors for adverse cutaneous reactions associated with intravenous vancomycin 显示文摘	Korman TM Tarnidge JD Grayson ML	1997	J Antimicrob Chemother1997，39，3：	1
9	Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers 显示文摘	Grayson ML Melvani S Druce J	2009	Clin infect Dis2009，48，3：	1
10	The treatment triangle for staphylococcal infections显示文摘	Grayson ML		0，，：	1
11	Clinical population pharmacokinetics and toxicodynamics of linezolid显示文摘	Boak LM Rayner CR Grayson ML	2014	Antimicrob Agents Chemother2014，58，4：	1
12	Risk factors for adverse cutaneous reactions associated with intravenous vancomycin显示文摘	Korman TM Turnidge JD Grayson ML	1997	J Antimicrob Chemother1997，39，3：	1
13	Comparison of daptomycin,vancomycin,and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci显示文摘	Ramos MC Grayson ML Eliopoulos GM	1992	Antimicrob Agents Chemother1992，36，9：	1
14	Antimicrobial resistance in the intensive care unit显示文摘	Grayson ML Eliopoulos GM	1990	Sem Respir Infect1990，5，3：	1
15	Quantitative efficacy of alcohol based hand rub against vaccomycin-resistant enterococci on the hands of human volunteers显示文摘	Grayson ML Ballard SA Gao W	2012	Infect control hosp epidermal2012，33，1：	1
16	The growing burden of multidrug-resistant infections among returned Australian travelers显示文摘	Chua KY Grayson ML Burgess AN	2014	Med J Aust2014，200，2：	1
17	The growing bur- den of multidrug-resistant infections among returned Austral- ian travellers显示文摘	Chua KY Grayson ML Burgess AN	2014	Med J Aust2014，200，2：	1
18	Dumb and dumber the potential waste of a useful antistaphylococcal agent : emerging fusidic acid resistance in Staphylococcus aureus 显示文摘	Howder BP Grayson ML	2006	Clin Infect Dis2006，42，3：	1
19	Risk factors for adverse cutaneous reactions associated with intra- venous vancomycin 显示文摘	Korman TM Turnidge JD Grayson ML	1997	J Antimicrob Chemother1997，39，3：	1
20	Risk factors for adverse cutaneous reactions associated with intravenous vancomycin显示文摘	Korman TM Turnidge JD Grayson ML	2007	J Antimicrob Chemother2007，39，3：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示